ANNALS OF NEUROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2024-03-09 1229554913 来自北京

审稿速度:1.0 | 投稿命中率:75.0
经验分享：审稿速度快

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2024-03-09 1229554913 来自北京

审稿速度:1.0 | 投稿命中率:75.0
经验分享：审稿速度快

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2023-10-21 ms3000000820351175 来自荷兰

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：血管病
经验分享：投稿后马上变成under review，两天后变成evaluating recomendation

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2023-05-08 1251f664m27暂无昵称来自山东省

投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？

67 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2023-03-02 ms8000001884736215 来自北京

审稿速度:2.0 | 投稿命中率:5.0
经验分享：第二天就Under Review，不知道啥意思

75 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2023-11-11 147f4ce1m48(暂无昵称) 来自北京

审稿速度:3.0 | 投稿命中率:50.0
经验分享：近几年要求较高，研究质量高可试试

41 0

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2022-05-27 12588598m48暂无昵称

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：neurology
经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！

123 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2022-12-09 ms1000000413306818 来自福建省

一个月过去了，还是under review，有人同样情况的吗

82 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2022-06-01 ms6000000601742295

投稿之后会给所有作者发邮件确认吗？

111 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2192206, encodeId=98fa21922065f, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:16:24 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192205, encodeId=99e92192205e0, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=193e2130235, createdName=1229554913, createdTime=Sat Mar 09 10:14:38 CST 2024, time=2024-03-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2164067, encodeId=deb8216406ee1, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：血管病 经验分享：投稿后马上变成under review，两天后变成evaluating recomendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29788127084, createdName=ms3000000820351175, createdTime=Sat Oct 21 10:10:02 CST 2023, time=2023-10-21, status=1, ipAttribution=荷兰), GetPortalCommentsPageByObjectIdResponse(id=2131011, encodeId=c3b8213101144, content=投了个letter，目前一个月了，还是在编辑手上，Under Review。不知道啥情况，有知道的道友说一下不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94c62540847, createdName=1251f664m27暂无昵称, createdTime=Mon May 08 19:11:26 CST 2023, time=2023-05-08, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2117137, encodeId=3077211e13723, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：第二天就Under Review，不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce4b8564886, createdName=ms8000001884736215, createdTime=Thu Mar 02 00:09:26 CST 2023, time=2023-03-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2167952, encodeId=30d5216e95222, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：近几年要求较高，研究质量高可试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c575257301, createdName=147f4ce1m48(暂无昵称), createdTime=Sat Nov 11 08:07:33 CST 2023, time=2023-11-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1222860, encodeId=2d4b12228606c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：neurology 经验分享：2021.11月投稿，经历2轮review，2022.5突然acccept了，好激动哦，我真的栓Q编辑和审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Fri May 27 20:35:17 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105092, encodeId=e789210509267, content=一个月过去了，还是under review，有人同样情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787d5616907, createdName=ms1000000413306818, createdTime=Fri Dec 09 16:14:51 CST 2022, time=2022-12-09, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1223750, encodeId=1e561223e5058, content=投稿之后会给所有作者发邮件确认吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c226530638, createdName=ms6000000601742295, createdTime=Wed Jun 01 01:51:13 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069294, encodeId=deb510692940a, content=在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62f12466313, createdName=1242a61em70暂无昵称, createdTime=Thu Nov 11 15:46:37 CST 2021, time=2021-11-11, status=1, ipAttribution=)]

2021-11-11 1242a61em70暂无昵称

在读小硕，最近怀着试一试的心态投了一个neuro-image，杂志效率之高令人惊叹投稿10-28 Evaluating recommendations 11-3 aecept 11-9.直接接收，实属意外之喜，在投稿jama neurology 和neurology接连被拒后，终于是在这个杂志看到曙光

183 11

展开11条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务